EWTX FY 2025 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

EWTXEdgewise Therapeutics, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$191M

Net Income

-$168M

EPS (Diluted)

$-1.63

Cash Flow

Operating Cash Flow

-$144M

Free Cash Flow

-$144M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$553M

Total Liabilities

$30M

Stockholders' Equity

$522M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$191M	-$159M	-20.5%
Net Income	-$168M	-$134M	-25.4%